enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of ulcerative colitis - Wikipedia

   en.wikipedia.org/wiki/Management_of_ulcerative...

   In some cases, sulfasalazine can exacerbate ulcerative colitis resulting in diarrhea, abdominal cramps and discomfort. In the intestine sulfasalazine is converted to 5-ASA and sulfapyridine, which is responsible for some of its side-effects, and which should be monitored in patients taking sulfasalazine.

3. Sulfasalazine - Wikipedia

   en.wikipedia.org/wiki/Sulfasalazine

   Sulfasalazine, sold under the brand name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. [5] It is considered by some to be a first-line treatment in rheumatoid arthritis. [6] It is taken by mouth or can be administered rectally. [5]

4. Ulcerative colitis - Wikipedia

   en.wikipedia.org/wiki/Ulcerative_colitis

   Ulcerative colitis (UC) is one of the two types of inflammatory bowel disease (IBD), with the other type being Crohn's disease. [1] It is a long-term condition that results in inflammation and ulcers of the colon and rectum. [1] [7] The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood (hematochezia). [1]

5. The Surprising Relationship Between Oral Health and IBD - AOL

   www.aol.com/surprising-relationship-between-oral...

   And that inflammation is especially perilous in the case of the inflammatory bowel diseases (IBD) Crohn’s disease and ulcerative colitis. People with IBD are more likely to have gum inflammation ...

6. Mesalazine - Wikipedia

   en.wikipedia.org/wiki/Mesalazine

   Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. [1] It is generally used for mildly to moderately severe disease. [1] It is taken by mouth or rectally. [1]

7. FDA-approved drug for ulcerative colitis also effective for ...

   www.aol.com/fda-approved-drug-ulcerative-colitis...

   Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.